Market:
Traditional multiomic analysis, the integrated analysis of proteins, lipids, electrolytes, small molecules, and so on, is costly and time-consuming. Specialized multiomic laboratories typically receive multiple samples, and their multiple bioinformatic analysis approach often risks data distortion. Dalton Bioanalytics has developed a mass spectrometry-based technology capable of profiling nearly all types of biologically important molecules using a single assay, dramatically reducing the cost of multiomics.Technology:
Utilizing tried-and-true liquid chromatography coupled mass spectrometry (LC-MS), Dalton Bioanalytics analyzes protein, lipids, electrolytes, nutrients, environmental chemicals, and other small molecules in a single-shot assay for the first time in history. Their coupled laboratory and computational techniques enable Dalton Bioanalytics to simultaneously identify and quantify thousands of analyses quickly and accurately.Advantages:
- More data for a lowered price
- Proteomic, lipidomic, metallomic, and metabolomic data in a single run
Development Stage:
- Commercial
Select Publications:
- Dalton Bioanalytics: comprehensive molecular analysis | Medium
- 20 in Their 20s: Seungjun Yeo | Los Angeles Business Journal
Contact:
Email: info@daltonbioanalytics.comPhone: 925-408-8778
Website: www.daltonbioanalytics.com
Social: LinkedIn
Portfolio Companies
- Active Membranes, LLC.
- Avesta76 Therapeutics
- Capacity Bio
- CDR3 Therapeutics, Inc.
- Dalton Bioanalytics
- EarlyDx
- Forcyte Biotechnologies
- Gradient Orthodontics
- ImmunoVec
- Lactation Lab
- Lookin, Inc.
- Nanoarmor, LLC.
- Partillion Bioscience Corporation
- Pelage Pharmaceuticals
- Pluto Immunotherapeutics
- Scarless Laboratories
- Sorriso Pharmaceuticals
- Symphony Biosciences
- Vault Pharma
- ViBo Health
- Westwood Bioscience